Papers

2

Total Citations

10

H-Index

2

About

G.S. Murkitt is a bioanalytical chemist whose pioneering work in the 1980s and 1990s advanced the automation of drug quantification in plasma. Their key research areas include high-performance liquid chromatography (HPLC), solid-phase extraction, and the development of fully automated bioanalytical assays for pharmaceutical compounds. Murkitt’s most cited paper, "Quantification of a positive inotropic agent in plasma: Towards total automation" (1987, 7 citations), introduced a novel approach to automating the analysis of cardiovascular drugs, reducing manual handling and improving throughput. This work laid the foundation for their later study, "Fully automated assay for the determination of GR117289X in human plasma using mixed mode solid-phase extraction and high-performance liquid chromatography with ultraviolet detection" (1994, 3 citations), which demonstrated a robust, integrated method for quantifying a specific angiotensin II receptor antagonist. Though their citation counts are modest, Murkitt’s contributions were notable for their time, reflecting an early commitment to laboratory automation that foreshadowed modern high-throughput bioanalysis. Their achievements highlight the critical role of method development in enabling reliable pharmacokinetic studies, making their work a valuable reference for researchers in pharmaceutical analysis and clinical chemistry.

Research Focus

Key Achievements

2
H-Index
2
Papers
10
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Quantification of a positive inotropic agent in plasma: Towards total automation
7 citations · 1987
📈 Most Prolific Year: 1987 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Smiths Detection (Canada), GlaxoSmithKline (United Kingdom)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago